跳至主要内容
临床试验/IRCT201705052624N23
IRCT201705052624N23招募中2 期

A comparison between the efficacy of intravascular betamethasone phosphate versus intra muscular betamethasone phosphate on neonates in the cases of emminant preterm birth.

Vice chancellor for research ,Iran University of Medical Sciences.0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • gestational age of 26-34 weeks; singleton pregnancy; cervical dilatation of equal or more than 3-4 cm and emminant preterm birth or delivery during less than 24 hours.
  • Exclusion criteria: known allergy for betamethazone; history of any known maternal systemic disorders like hypertension, diabetes, liver and cardiac disease, renal failure and neoplasia.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research ,Iran University of Medical Sciences.

相似试验